FDA UNTITLED_LETTER - Wedgewood Connect, LLC - November 09, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This UNTITLED LETTER record concerns Wedgewood Connect, LLC, with an inspection on November 9, 2023, issued by the Division of Pharmaceutical Quality Operations I, covering drugs.

Company: Wedgewood Connect, LLC
Inspection Date: November 9, 2023
Product Type: Drugs
Office: Division of Pharmaceutical Quality Operations I
People: Steven E. Porter (Program Division Director)
Lance M. De Souza (Director - Compliance Branch)
Andrew K. Haack (Compliance Officer)
Marcy Bliss

Open in Dashboard

ID · c7b71d6a-971e-480f-9e52-95939c6a80af

Violation Codes10

21 U.S.C. 331(d)21 CFR 211.113(b)21 U.S.C. 321(p)21 CFR 211.42(c)(10)(iv)21 U.S.C. 331(a)21 CFR 211.165(d)21 U.S.C. 331(k)21 U.S.C. 360eee-121 U.S.C. 351(a)(2)(A)21 U.S.C. 321(g)

Full citation text and observation details available on the Dashboard.